Os11g0586001 Antibody

Shipped with Ice Packs
In Stock

Description

Basic Characterization of Os11g0586001 Antibody

Product Name: Os11g0586001 Antibody
Code: CSB-PA384950XA01OFG
UniProt No.: A3CCP9
Species: Oryza sativa subsp. japonica (Rice)
Size: 2 ml (working aliquot) / 0.1 ml (trial aliquot)
Host Species: Likely rabbit or mouse (exact host unspecified in available data)
Format: Unconjugated IgG

ParameterValueSource
Target ProteinOs11g0586001
ClonalityPolyclonal (assumed)
ApplicationsELISA, WB, IHC (presumed)
ValidationNot explicitly stated

Biological Context of Os11g0586001 Protein

The Os11g0586001 protein is a rice-specific gene product with limited publicly available functional annotation. Key inferred details:

  • Gene ID: Os11g0586001 (LOC_Os11g0586001)

  • Chromosomal Location: Chromosome 11

  • Protein Class: Uncharacterized (conserved in Oryza species)

  • Domains: No Pfam domains identified in UniProt entry A3CCP9.

Development and Use Cases

  • Custom Antibody Production: Developed by Cusabio as part of a specialized catalog for rare plant targets .

  • Target Applications: Likely used in rice proteomics, stress-response studies, or genetic engineering validation.

Known Limitations

  • No peer-reviewed studies directly citing Os11g0586001 Antibody were identified in PubMed, PMC, or other academic databases .

  • Functional studies of the Os11g0586001 protein are absent from published literature.

Comparative Analysis of Rice Antibodies

The table below contextualizes Os11g0586001 Antibody among other rice-targeting antibodies from the same catalog :

Antibody NameCodeUniProt No.Target Function
PP2C50 AntibodyCSB-PA757205XA01OFGQ6L5H6Protein phosphatase 2C
PARP1 AntibodyCSB-PA765912XA01OFGQ7EYV7Poly(ADP-ribose) polymerase
HCF136 AntibodyCSB-PA716926XA01OFGQ5Z5A8Photosystem II stability
Os11g0586001CSB-PA384950XA01OFGA3CCP9Uncharacterized

Future Directions

  • Functional Studies: Role of Os11g0586001 in rice development, stress adaptation, or pathogen resistance.

  • Technical Validation: Western blot or immunohistochemistry data to confirm specificity.

  • Collaborative Research: Partnerships between agricultural biotech firms and academic institutions could accelerate discovery.

Key Challenges

  • Epitope Mapping: No structural or epitope data exists for this antibody.

  • Cross-Reactivity Risks: Unknown due to lack of validation studies.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Os11g0586001 antibody; LOC_Os11g37540 antibody; Putative protein phosphatase 2C 76 antibody; OsPP2C76 antibody; EC 3.1.3.16 antibody
Target Names
Os11g0586001
Uniprot No.

Q&A

What is Os11g0586001 protein and what is its function in rice?

Os11g0586001 refers to a gene that encodes the putative protein phosphatase 2C 76 (OsPP2C76), a serine/threonine phosphatase with the EC number 3.1.3.16, found in Oryza sativa subsp. japonica (Rice) . Protein phosphatase 2C (PP2C) family members play crucial roles in cellular signaling pathways, particularly in stress responses and developmental processes in plants. PP2Cs typically function as negative regulators in abscisic acid (ABA) signaling pathways and other stress-responsive mechanisms.

OsPP2C76 specifically belongs to a large family of PP2Cs in rice, with research suggesting its involvement in environmental stress responses such as drought, salinity, or temperature fluctuations. The protein is characterized by its conserved catalytic domain responsible for dephosphorylation activity, which modifies the activity of substrate proteins by removing phosphate groups from phosphorylated serine or threonine residues.

What are the key specifications of commercially available Os11g0586001 antibodies?

The Os11g0586001 antibody is available as a polyclonal antibody raised in rabbits against recombinant Oryza sativa subsp. japonica Os11g0586001 protein . The key specifications include:

ParameterSpecification
Antibody TypePolyclonal
Host SpeciesRabbit
Target SpeciesOryza sativa subsp. japonica (Rice)
ClonalityPolyclonal
IsotypeIgG
FormLiquid
UniProt AccessionA3CCP9
ApplicationsELISA, Western Blot
Storage Buffer50% Glycerol, 0.01M PBS (pH 7.4), 0.03% Proclin 300
Storage Conditions-20°C or -80°C
Purification MethodAntigen Affinity Purified
Lead TimeMade-to-order (14-16 weeks)

These specifications are critical for researchers to evaluate the suitability of the antibody for their specific experimental needs and to ensure proper handling of the reagent .

What applications is the Os11g0586001 antibody validated for in plant research?

The Os11g0586001 antibody has been validated for specific research applications in plant molecular biology and biochemistry. Based on available information, the antibody is primarily tested and validated for:

  • Enzyme-Linked Immunosorbent Assay (ELISA): The antibody can effectively detect the target protein in ELISA-based assays, making it suitable for quantitative analysis of Os11g0586001 expression levels in rice tissue extracts .

  • Western Blot (WB): The antibody is validated for western blot applications, allowing for the detection and semi-quantification of the target protein based on molecular weight in protein extracts from rice tissues .

When using this antibody for these applications, researchers should ensure proper protocol optimization, including appropriate dilution determination, blocking conditions, and detection methods. While these are the confirmed applications, researchers often adapt antibodies for other techniques such as immunoprecipitation (IP) or immunohistochemistry (IHC) after conducting validation experiments for their specific conditions.

How can I optimize Western blot protocols for detecting Os11g0586001 in different rice tissue samples?

Optimizing Western blot protocols for Os11g0586001 detection requires careful consideration of several parameters to maximize signal-to-noise ratio and ensure reproducible results. The following methodological approach is recommended:

  • Sample Preparation:

    • Extract proteins from rice tissues using buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 5 mM EDTA, and protease inhibitor cocktail.

    • For phosphatase studies, include phosphatase inhibitors (e.g., 10 mM NaF, 1 mM Na3VO4).

    • Homogenize tissues thoroughly in ice-cold buffer (4:1 buffer-to-tissue ratio).

    • Centrifuge at 12,000g for 15 minutes at 4°C and collect supernatant.

  • Protein Separation:

    • Load 20-50 μg total protein per lane on 10-12% SDS-PAGE gels.

    • Include a positive control (recombinant Os11g0586001 protein if available).

    • Run at 100V until the dye front reaches the bottom of the gel.

  • Transfer and Blocking:

    • Transfer proteins to PVDF membrane (0.45 μm) at 100V for 1 hour in cold transfer buffer.

    • Block with 5% non-fat dry milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature.

  • Antibody Incubation:

    • Start with 1:1000 dilution of Os11g0586001 antibody in 1% BSA in TBST.

    • Incubate overnight at 4°C with gentle rocking.

    • Wash 3 times with TBST, 10 minutes each.

    • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour at room temperature.

    • Wash 3 times with TBST, 10 minutes each.

  • Detection:

    • Use ECL substrate with exposure times of 30 seconds to 5 minutes.

    • For low abundance, consider enhanced chemiluminescence substrates or signal amplification systems.

For different tissue types, protein extraction protocols may need adjustment. Reproductive tissues often require additional detergents (increase to 1.5% Triton X-100), while leaf tissues may need more mechanical disruption. Calibrate loading controls carefully as expression of typical housekeeping genes may vary across tissue types.

How can I use the Os11g0586001 antibody for studying protein-protein interactions in stress response pathways?

Investigating protein-protein interactions involving Os11g0586001/OsPP2C76 can provide valuable insights into stress signaling networks in rice. The following methodological approaches are recommended:

  • Co-Immunoprecipitation (Co-IP):

    • Prepare plant extracts in non-denaturing lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1% NP-40, 2 mM EDTA, 10% glycerol with protease inhibitors).

    • Pre-clear lysate with Protein A/G beads for 1 hour at 4°C.

    • Incubate with Os11g0586001 antibody (5-10 μg per 1 mg protein) overnight at 4°C.

    • Add fresh Protein A/G beads and incubate for 2-4 hours.

    • Wash beads 4-5 times with wash buffer.

    • Elute complexes with SDS sample buffer and analyze by Western blot using antibodies against potential interacting partners.

  • Proximity Ligation Assay (PLA) for in situ detection:

    • Fix plant tissue sections in 4% paraformaldehyde.

    • Perform antigen retrieval if necessary.

    • Block with appropriate blocking solution.

    • Incubate with Os11g0586001 antibody and antibody against candidate interacting protein.

    • Follow PLA protocol with species-specific PLA probes.

    • Detect signals using fluorescence microscopy.

  • Pull-down assays with potential interacting proteins:

    • Express recombinant potential interactors with affinity tags.

    • Immobilize on appropriate resin.

    • Incubate with plant extracts containing Os11g0586001.

    • Detect bound Os11g0586001 using the antibody by Western blot.

When studying stress responses, consider comparing protein interactions under normal and stress conditions (e.g., drought, salinity, or temperature stress). Treatment with stress hormones like abscisic acid (ABA) can also provide insights into pathway regulation. Negative controls (non-specific IgG) and positive controls (known interacting pairs) should be included in all experiments.

What are the best methods for quantifying Os11g0586001 protein expression levels across different developmental stages?

Accurate quantification of Os11g0586001 protein expression requires combination of multiple techniques. The following methodological framework is recommended:

  • Quantitative Western Blot:

    • Collect rice tissues at specific developmental stages under standardized conditions.

    • Extract proteins using consistent buffer-to-tissue ratios.

    • Include a standard curve of recombinant Os11g0586001 protein (5-100 ng range).

    • Use the Os11g0586001 antibody at optimized dilution (typically 1:1000).

    • Employ fluorescent secondary antibodies rather than HRP-conjugated ones for better quantification.

    • Analyze using digital imaging systems capable of linear detection over wide dynamic range.

    • Normalize to total protein (measured by Stain-Free technology or Ponceau S staining) rather than single housekeeping proteins.

  • Quantitative ELISA:

    • Develop a sandwich ELISA using the Os11g0586001 antibody as capture or detection antibody.

    • Create standard curves using recombinant protein.

    • Prepare tissue extracts in ELISA-compatible buffers.

    • Measure absorbance using a spectrophotometer at appropriate wavelength.

    • Calculate concentrations using the standard curve.

  • Comparative analysis system:

    • Integrate data from both methods using the following table format:

Developmental StageWestern Blot (ng/mg total protein)ELISA (ng/mg total protein)Relative Expression
Seedling (7 days)[Value ± SD][Value ± SD][normalized value]
Vegetative (30 days)[Value ± SD][Value ± SD][normalized value]
Reproductive (60 days)[Value ± SD][Value ± SD][normalized value]
Grain filling[Value ± SD][Value ± SD][normalized value]
Maturity[Value ± SD][Value ± SD][normalized value]
  • Statistical analysis:

    • Perform at least three biological replicates and three technical replicates.

    • Apply appropriate statistical tests (ANOVA followed by post-hoc tests) to determine significant differences between developmental stages.

    • Calculate coefficients of variation to assess method reliability.

This comprehensive approach provides robust quantification data across developmental stages, allowing for accurate assessment of Os11g0586001 temporal expression patterns.

How should I design experiments to study Os11g0586001 phosphatase activity in relation to abiotic stress responses?

Designing experiments to investigate Os11g0586001 (OsPP2C76) phosphatase activity in abiotic stress responses requires a systematic approach that integrates biochemical, molecular, and physiological methods. The following experimental framework is recommended:

  • Phosphatase Activity Assays:

    • Immunoprecipitate Os11g0586001 from plant tissues using the antibody.

    • Measure phosphatase activity using synthetic phosphopeptide substrates or para-nitrophenylphosphate (pNPP).

    • Compare activity under control and stress conditions (drought, salt, cold).

    • Include appropriate controls: heat-inactivated enzyme and phosphatase inhibitors.

    • Experiment design:

Treatment GroupTissue Collection TimepointsBiological ReplicatesTechnical Replicates
Control0h, 1h, 3h, 6h, 12h, 24h53
Drought (20% PEG)0h, 1h, 3h, 6h, 12h, 24h53
Salt (150 mM NaCl)0h, 1h, 3h, 6h, 12h, 24h53
Cold (4°C)0h, 1h, 3h, 6h, 12h, 24h53
  • Substrate Identification:

    • Perform phosphoproteomic analysis of control and stress-treated rice tissues.

    • Identify differentially phosphorylated proteins.

    • Test these as potential substrates in in vitro dephosphorylation assays with immunoprecipitated Os11g0586001.

    • Confirm interactions by Co-IP using the Os11g0586001 antibody.

  • Functional Analysis in Planta:

    • Generate transgenic rice with altered Os11g0586001 expression (overexpression and RNAi/CRISPR knockdown).

    • Subject plants to controlled stress conditions.

    • Measure physiological parameters (relative water content, electrolyte leakage, photosynthetic efficiency).

    • Analyze stress marker gene expression.

    • Compare phosphorylation status of identified substrates using phospho-specific antibodies.

  • Kinetic Analysis of Enzyme Activity:

    • Assess kinetic parameters (Km, Vmax) of purified Os11g0586001 under different stress conditions.

    • Test effects of potential regulators (ions, metabolites) on activity.

    • Design competition assays to determine substrate preferences.

    • Create substrate specificity profiles using peptide arrays.

For all experiments, use the Os11g0586001 antibody to confirm the presence and levels of the protein. Statistical analysis should include appropriate parametric or non-parametric tests based on data distribution, with significance typically set at p<0.05.

What controls and validation steps should be included when using Os11g0586001 antibody for immunolocalization studies?

Immunolocalization studies using Os11g0586001 antibody require rigorous controls and validation steps to ensure specific, reproducible, and biologically meaningful results. The following comprehensive approach is recommended:

  • Antibody Specificity Controls:

    • Western blot validation: Confirm antibody recognizes a single band of expected molecular weight in tissue lysates.

    • Pre-adsorption control: Pre-incubate antibody with excess recombinant Os11g0586001 protein before use in immunolocalization.

    • Genetic controls: Include tissues from knockout/knockdown lines or overexpression lines if available.

    • Cross-reactivity testing: Test antibody against related PP2C family members to ensure specificity.

  • Technical Controls for Immunolocalization:

    • Negative controls:

      • Primary antibody omission: Replace primary antibody with same concentration of non-immune rabbit IgG.

      • Secondary antibody controls: Perform procedure with secondary antibody only.

    • Positive controls:

      • Include tissues known to express Os11g0586001 based on transcriptomic data.

      • Use recombinant Os11g0586001-expressing cells if available.

    • Autofluorescence controls:

      • Examine unstained tissue sections to assess natural autofluorescence.

      • Include appropriate quenching steps if necessary.

  • Protocol Validation Matrix:

    • Systematically optimize key parameters:

ParameterTest RangeEvaluation Criteria
Fixation2-4% PFA, cold acetone, methanolStructural preservation, epitope accessibility
Antigen retrievalCitrate buffer pH 6.0, Tris-EDTA pH 9.0, enzymaticSignal intensity, background
Blocking1-10% BSA, normal serum, commercial blockersBackground reduction
Antibody dilution1:100 - 1:2000Signal-to-noise ratio
Incubation time1 hour RT, overnight 4°CSignal intensity, specificity
Detection systemVarious fluorophores or chromogensSensitivity, compatibility
  • Biological Validation:

    • Correlate protein localization with mRNA expression (by in situ hybridization).

    • Compare localization patterns across developmental stages.

    • Assess changes in localization under experimental conditions (e.g., stress treatments).

    • Confirm subcellular localization using fractionation followed by Western blot.

  • Technical Replication and Quantification:

    • Perform at least three biological replicates with multiple technical replicates.

    • Develop quantification methods (fluorescence intensity, colocalization coefficients).

    • Use appropriate statistical analyses for comparative studies.

Implementing this validation framework ensures reliable immunolocalization results that accurately reflect the biological distribution of Os11g0586001 protein in rice tissues.

What are common troubleshooting strategies when Os11g0586001 antibody fails to detect the target protein in Western blots?

When experiencing detection issues with Os11g0586001 antibody in Western blots, a systematic troubleshooting approach should be implemented. The following methodological strategies address common problems:

  • Sample Preparation Issues:

    • Protein degradation: Ensure complete protease inhibitor cocktail is used. Consider adding higher concentrations of protease inhibitors or using fresh tissue samples.

    • Insufficient extraction: Try alternative extraction buffers (RIPA, urea-based buffers) that may better solubilize the protein.

    • Protein modification: Add phosphatase inhibitors if the protein is regulated by phosphorylation, which might affect antibody recognition.

    • Sample analysis table:

IssueDiagnostic TestSolution
DegradationRun time-course of extraction to detect fragmentsAdd higher concentration of protease inhibitors
Poor solubilizationCompare different extraction buffersSelect buffer with highest yield
Protein modificationAdd phosphatase inhibitors to half sampleCompare detection with/without inhibitors
  • Technical Parameters:

    • Antibody concentration: Test serial dilutions from 1:500 to 1:5000.

    • Blocking conditions: Try different blocking agents (5% milk, 3-5% BSA, commercial blockers).

    • Incubation time and temperature: Compare overnight at 4°C versus 2-4 hours at room temperature.

    • Enhanced detection: Use high-sensitivity ECL substrates or signal amplification systems.

    • Secondary antibody: Test different concentrations and suppliers of anti-rabbit HRP conjugates.

  • Transfer Issues:

    • Transfer efficiency: Verify with Ponceau S staining or reversible total protein stains.

    • Membrane type: Compare PVDF (0.2 μm and 0.45 μm) and nitrocellulose membranes.

    • Transfer conditions: Test different buffer compositions (with/without SDS or methanol) and transfer times.

  • Protein Detection Optimization:

    • Protein amount: Increase loading to 50-100 μg total protein per lane.

    • Protein size verification: Use protein markers to confirm migration at expected molecular weight.

    • Enhance epitope exposure: Test mild membrane treatment with 0.1% SDS before antibody incubation.

    • Alternative detection: Consider using AP-conjugated secondary antibodies with BCIP/NBT substrate.

  • Antibody Verification:

    • Antibody quality: Test a new lot of antibody if possible.

    • Verify with positive control: Use recombinant Os11g0586001 protein as positive control.

    • Cross-reactivity: Confirm antibody specificity by testing against related PP2C proteins.

Document all troubleshooting steps systematically, changing only one parameter at a time to identify the critical factor(s) affecting detection. This methodical approach will help optimize conditions for successful Os11g0586001 detection.

How can I analyze and interpret contradictory results when comparing Os11g0586001 protein levels with gene expression data?

Discrepancies between protein abundance (detected by Os11g0586001 antibody) and mRNA expression can provide valuable biological insights but require careful analysis. The following methodological framework helps address and interpret such contradictions:

  • Verification of Data Validity:

    • Confirm antibody specificity through additional validation techniques.

    • Verify primer specificity and efficiency for qRT-PCR.

    • Ensure appropriate reference genes/proteins are used for normalization.

    • Check for technical artifacts in both protein and RNA methods.

  • Temporal Analysis Framework:

    • Design time-course experiments with finer resolution sampling:

Time PointProtein Level (Western Blot)mRNA Level (qRT-PCR)Protein:mRNA Ratio
0h[Value ± SD][Value ± SD][Calculated Ratio]
1h[Value ± SD][Value ± SD][Calculated Ratio]
3h[Value ± SD][Value ± SD][Calculated Ratio]
6h[Value ± SD][Value ± SD][Calculated Ratio]
12h[Value ± SD][Value ± SD][Calculated Ratio]
24h[Value ± SD][Value ± SD][Calculated Ratio]
  • Biological Interpretation Framework:

    • Post-transcriptional regulation: Assess miRNA targeting Os11g0586001 mRNA.

    • Translational efficiency: Conduct polysome profiling to examine translation rates.

    • Protein stability: Perform cycloheximide chase experiments to determine protein half-life.

    • Alternative splicing: Design primers to detect specific splice variants and compare with protein detection.

  • Protein Degradation Analysis:

    • Treat samples with proteasome inhibitors (MG132) to assess if protein is subject to proteasomal degradation.

    • Compare protein abundance in various subcellular fractions to assess compartmentalization.

    • Test effects of phosphatase inhibitors on protein stability (given that Os11g0586001 is a phosphatase).

  • Statistical Analysis and Modeling:

    • Calculate Pearson or Spearman correlation coefficients between mRNA and protein data.

    • Apply time-lag analysis to account for delays between transcription and translation.

    • Develop mathematical models that incorporate rates of transcription, translation, and degradation.

    • Perform statistical tests (t-tests, ANOVA) to determine if differences are significant.

  • Integrative Analysis Approach:

    • Compare with phosphoproteomic data to assess if protein activity (rather than abundance) correlates with gene expression.

    • Examine epigenetic modifications at the Os11g0586001 locus using ChIP-seq data if available.

    • Consider post-translational modifications that might affect antibody recognition but not protein function.

These comprehensive methods help distinguish between technical artifacts and true biological regulatory mechanisms. Often, discrepancies reveal important regulatory layers such as post-transcriptional regulation, controlled protein degradation, or condition-specific protein modifications that affect function independently of abundance.

How can I use active learning approaches to improve antibody-antigen binding prediction for Os11g0586001-related studies?

Active learning methodologies can significantly enhance antibody-antigen binding prediction for Os11g0586001 studies, potentially reducing experimental costs while improving accuracy. The following framework adapts approaches from modern computational immunology to plant antibody research:

  • Data Collection and Initial Model Development:

    • Gather existing binding data for Os11g0586001 antibody and related plant protein phosphatases.

    • Develop a baseline machine learning model using sequence features, structural predictions, and physicochemical properties.

    • Create a validation dataset with known positive and negative binding examples.

  • Implementation of Active Learning Strategies:

    • Apply uncertainty sampling: Select epitope candidates where the model is least confident.

    • Use diversity sampling: Choose structurally diverse epitope candidates to broadly explore the binding space.

    • Implement query-by-committee: Train multiple models and select candidates with highest disagreement.

  • Experimental Validation Cycle:

    • Design a library-on-library screening approach where multiple antibody variants are tested against multiple Os11g0586001 variants/fragments.

    • Prioritize testing of selected candidates from active learning algorithms.

    • Update the model with new experimental data after each round.

    • Measure performance improvement using metrics like AUC, F1-score, and precision-recall curves.

  • Performance Comparison Matrix:
    Based on findings from related antibody-antigen prediction research :

Active Learning StrategyResource ReductionLearning Speed ImprovementOut-of-Distribution Performance
Uncertainty SamplingUp to 30%~20 stepsModerate
Diversity SamplingUp to 25%~15 stepsGood
Query-by-CommitteeUp to 35%~28 stepsExcellent
Random Selection (Baseline)0%0 stepsPoor
  • Implementation Protocol:

    • Start with a small labeled subset (10-20% of potential epitopes).

    • Use three-fold cross-validation to evaluate model performance.

    • Implement iterative cycles of:
      a. Model training on current data
      b. Candidate selection using the best-performing active learning strategy
      c. Experimental validation
      d. Model updating

    • Continue until performance plateaus or budget constraints are reached.

  • Computational Tools and Resources:

    • Leverage simulation frameworks like Absolut! for in silico testing of active learning strategies .

    • Utilize existing antibody-epitope databases and add Os11g0586001-specific data.

    • Implement ensemble methods combining sequence-based and structure-based predictions.

    • Consider transfer learning from well-characterized antibody-antigen systems to the plant phosphatase domain.

This approach can reduce the number of required experimental tests by up to 35% while accelerating the development of accurate binding prediction models . The resulting model will be particularly valuable for designing new antibodies targeting specific domains or post-translationally modified forms of Os11g0586001.

What are the future research directions for Os11g0586001 antibody applications in plant stress biology?

The Os11g0586001 antibody represents an important tool for advancing our understanding of protein phosphatase functions in rice stress responses. Several promising future research directions emerge from current knowledge and methodological capabilities:

  • Single-Cell Applications: Developing protocols for using Os11g0586001 antibody in single-cell proteomics to understand cell-type specific responses to environmental stresses. This approach would reveal how PP2C activity varies between different cell types within the same tissue under stress conditions, potentially identifying specialized regulatory networks.

  • Structural Biology Integration: Combining antibody-based detection with structural studies to understand how phosphatase conformation changes under different environmental conditions. The antibody could be used to capture specific conformational states for crystallization or cryo-EM studies, providing insights into activation mechanisms.

  • Systems Biology Approaches: Integrating Os11g0586001 antibody-based proteomics with transcriptomics, metabolomics, and phenomics data to develop comprehensive models of stress response networks in rice. This multi-omics approach would place PP2C activity in the broader context of cellular signaling and metabolic adaptations.

  • Translational Research Applications: Expanding the use of Os11g0586001 antibody to study orthologous PP2Cs in agriculturally important cereal crops beyond rice. Comparative studies could reveal conserved and divergent roles of these phosphatases in stress tolerance, potentially identifying targets for crop improvement.

  • Post-Translational Modification Mapping: Developing modified antibodies that specifically recognize phosphorylated, ubiquitinated, or otherwise modified forms of Os11g0586001 to understand its own regulation. This approach would help elucidate the upstream regulators of PP2C activity.

As research techniques continue to evolve, the Os11g0586001 antibody will likely find applications in emerging methodologies such as spatial proteomics, proximity labeling, and high-throughput phenotyping platforms. These advanced applications will deepen our understanding of protein phosphatase biology and potentially contribute to the development of stress-tolerant crop varieties.

How can researchers effectively document and share methodological advancements with Os11g0586001 antibody?

Effective documentation and sharing of methodological advancements with Os11g0586001 antibody are crucial for research reproducibility and advancement. Researchers should adopt the following comprehensive framework:

  • Detailed Protocol Documentation:

    • Create step-by-step protocols with precise reagent information including antibody catalog numbers, lot numbers, and suppliers .

    • Document all optimization steps with quantifiable parameters rather than subjective assessments.

    • Include troubleshooting decision trees based on experimental outcomes.

    • Use protocol repositories such as protocols.io, with version control to track methodological evolution.

  • Validation Data Sharing:

    • Publish full antibody validation data including Western blots showing specificity.

    • Include negative controls (pre-immune serum, isotype controls) and positive controls.

    • Document cross-reactivity testing against related PP2C family members.

    • Share raw images of blots and immunostaining alongside processed data.

  • Open Science Practices:

    • Deposit raw data in appropriate repositories (e.g., PRIDE for proteomics data).

    • Share analytical code through platforms like GitHub or Code Ocean.

    • Consider pre-registration of experimental designs when appropriate.

    • Adopt CRediT (Contributor Roles Taxonomy) to clearly document contributions to methodological advancements.

  • Standardized Reporting:

    • Follow relevant reporting guidelines such as MDAR (Materials, Design, Analysis and Reporting).

    • Use consistent terminology for describing antibody applications and validation.

    • Implement RRID (Research Resource Identifiers) for the Os11g0586001 antibody across publications.

    • Document key parameters in standardized formats:

ParameterDocumentation Recommendation
Antibody validationWestern blot images, peptide competition assays
Dilution optimizationTitration curves with signal-to-noise ratios
Specificity testingCross-reactivity data with related proteins
Application protocolsComplete methods with all buffer compositions
Batch variationComparison between different antibody lots
  • Community Engagement:

    • Establish collaborative networks focused on plant phosphatase research.

    • Organize method-focused workshops or webinars for knowledge sharing.

    • Create online resources dedicated to Os11g0586001 research techniques.

    • Develop mentoring systems pairing experienced and new users of the antibody.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.